| Q35197016 | A Role for Sigma Receptors in Stimulant Self Administration and Addiction. |
| Q46269870 | A behavioral and pharmacological characterization of palatable diet alternation in mice |
| Q24611779 | A novel substituted piperazine, CM156, attenuates the stimulant and toxic effects of cocaine in mice |
| Q43450779 | A selective sigma-2 receptor ligand antagonizes cocaine-induced hyperlocomotion in mice. |
| Q35163209 | Cholesterol at the endoplasmic reticulum: roles of the sigma-1 receptor chaperone and implications thereof in human diseases |
| Q35528967 | Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction |
| Q36494168 | Cocaine occupancy of sigma1 receptors and dopamine transporters in mice |
| Q52602721 | Dezocine Alleviates Morphine-Induced Dependence in Rats. |
| Q48415541 | Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward |
| Q36870910 | Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine |
| Q35592193 | Gene expression in the addicted brain |
| Q48134726 | Inhibitory effects of SA4503 on the rewarding effects of abused drugs |
| Q36995785 | Insights into the Sigma-1 receptor chaperone's cellular functions: a microarray report |
| Q24683869 | Interactions between 3,4-methylenedioxymethamphetamine and sigma1 receptors |
| Q36099544 | Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 cells |
| Q37545379 | Pharmacology and therapeutic potential of sigma(1) receptor ligands |
| Q24656937 | Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine |
| Q28570788 | Restraint-induced fra-2 and c-fos expression in the rat forebrain: relationship to stress duration |
| Q35901271 | Role of Sigma Receptor in Cocaine-Mediated Induction of Glial Fibrillary Acidic Protein: Implications for HAND |
| Q36610032 | Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists. |
| Q39185737 | Sigma Receptors and Substance Use Disorders |
| Q37000551 | Sigma receptors [σRs]: biology in normal and diseased states |
| Q30546325 | Stimulants as specific inducers of dopamine-independent σ agonist self-administration in rats |
| Q34438529 | Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems |
| Q24622567 | Targeting sigma receptors: novel medication development for drug abuse and addiction |
| Q42700435 | The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum |
| Q43075979 | The genetic epidemiology of substance use disorder: A review |
| Q37445561 | The pharmacology of sigma-1 receptors |
| Q36653400 | The sigma-1 receptor: roles in neuronal plasticity and disease |
| Q35920289 | dextro-Morphine attenuates the morphine-produced conditioned place preference via the sigma(1) receptor activation in the rat. |